What is Supha Pharmachem Ltd. Quarterly Revenue?

Supha Pharmachem Ltd. Quarterly Revenue Supha Pharmachem Sep-2025 Quarterly Revenue is Rs 12 Cr which is growth of -54.3% YoY.

What is Supha Pharmachem Ltd. Quarterly Net Profit?

Supha Pharmachem Ltd. Quarterly Net Profit Supha Pharmachem Sep-2025 Quarterly Net Profit is Rs 0 Cr which is growth of -95.8% YoY.

What is Supha Pharmachem Ltd. Annual Revenue?

Supha Pharmachem Ltd. Annual Revenue Supha Pharmachem Mar-2025 Annual Revenue is Rs 233 Cr which is growth of -94.3% YoY.

What is Supha Pharmachem Ltd. Annual Net Profit?

Supha Pharmachem Ltd. Annual Net Profit Supha Pharmachem Mar-2025 Annual Net Profit is Rs 2 Cr which is growth of -95.3% YoY.

What is Supha Pharmachem Ltd. Total Shareholders Fund?

Supha Pharmachem Ltd. Total Shareholders Fund Supha Pharmachem Mar-2025 Total Shareholders Fund is Rs 43 Cr which is growth of 0.8% YoY.

What is Supha Pharmachem Ltd. Total Assets?

Supha Pharmachem Ltd. Total Assets Supha Pharmachem Mar-2025 Total Assets is Rs 1,540 Cr which is growth of -21.0% YoY.

What is Supha Pharmachem Ltd. Book Value Per Share?

Supha Pharmachem Ltd. Book Value Per Share Supha Pharmachem Mar-2025 Book Value Per Share is 1 Rs which is growth of -74.8% YoY.

What is Supha Pharmachem Ltd. ROE?

Supha Pharmachem Ltd. ROE Supha Pharmachem Mar-2025 ROE is 4% which is growth of 72.7% YoY.

What is Supha Pharmachem Ltd. Cash From Operating Activity?

Supha Pharmachem Ltd. Cash From Operating Activity Supha Pharmachem Mar-2025 Cash From Operating Activity is Rs 0 Cr which is growth of 0% YoY.

What is Supha Pharmachem Ltd. Net Cash Flow?

Supha Pharmachem Ltd. Net Cash Flow Supha Pharmachem Mar-2025 Net Cash Flow is Rs 0 Cr which is growth of 100.0% YoY.

Supha Pharmachem Ltd.

BSE: 539561

Download real time

0.00(0.00%)

New 52W Low today

1.5M

BSE Volume

BSE 08 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Supha Pharmachem quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Supha Pharmachem quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Supha Pharmachem Sep-2025 Quarterly Revenue is Rs 12 Cr which is growth of -54.3% YoY.
NEGATIVE
Quarterly Net Profit Supha Pharmachem Sep-2025 Quarterly Net Profit is Rs 0 Cr which is growth of -95.8% YoY.

Supha Pharmachem Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23	Mar '23	Dec '22	Sep '22
TOTAL_SR_Q Total Rev. ⌄	11.8	21.9	82.2	45.6	25.9	79.6	1,411.4	1,848.3	472.7	330.5	75.6	176.5	160
SR_Q Operating Rev.	8.6	18.4	81.6	38.2	25.1	77.7	1,408.5	1,834.2	468.6	330.5	75.6	176.5	158.5
OI_Q Other Income	3.3	3.5	0.7	7.4	0.8	1.9	2.9	14.1	4.1			0	1.6
OEXPNS_Q Operating Exp.	11.6	22.6	82.8	43.6	20.6	77.3	1,443.5	1,779.5	462.2	323.2	78.5	175	156.3
OEXPNS_Q Operating Exp.	11.6	22.6	82.8	43.6	20.6	77.3	1,443.5	1,779.5	462.2	323.2	78.5	175	156.3
OP_Q Operating Profit	-3	-4.2	-1.2	-5.5	4.5	0.4	-35	54.7	6.3	7.3	-2.9	1.5	2.1
OPMPCT_Q Operating Profit Margin %	-34.87%	-22.90%	-1.44%	-14.36%	17.77%	0.50%	-2.49%	2.98%	1.35%	2.20%	-3.83%	0.87%	1.35%
DEP_Q Depr.			0	0	0	0	0	0	0	0	0	0	0
INT_Q Interest	0.2	-0.4	1.6	0.9	2.8		3.9	0			-0.1	0
PBT_Q Profit Before Tax	0.1	-0.4	-2.1	1.1	2.5	2.3	-36	68.8	10.4	7.3	-2.8	1.5	2.2
TAX_Q Tax			0.5	0.3	0.7	0.6	17.7		3.1	2	2
NP_Q Net Profit	0.1	-0.4	-2.6	0.8	1.8	1.6	-53.7	68.8	7.3	5.3	-4.8	1.5	2.2
EPS_adj_Q EPS Adj. latest			-0	0	0	0	-0.6	0.8	0.1	0.1	-0.1	0	0
NP_TTM Net profit TTM	-2.2	-0.5	1.5	-49.5	18.5	24	27.6	76.5	9.3	4.2	5.4	9	8.2
EPS_TTM Basic EPS TTM	-0	-0	0	-1.2	0.5	2.4	2.7	38	4.6	11.6	15.1	25.1	22.8
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes		Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Supha Pharmachem competitor comparison and performance snapshot within industry

Supha Pharmachem annual results: revenue, profit, P&L, and margins as of Mar 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Annual Revenue Supha Pharmachem Mar-2025 Annual Revenue is Rs 233 Cr which is growth of -94.3% YoY.
NEGATIVE
Annual Net Profit Supha Pharmachem Mar-2025 Annual Net Profit is Rs 2 Cr which is growth of -95.3% YoY.

Supha Pharmachem Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15
SR_A Total Rev. Ann. ⌄	-22.7%	140.5%	161.5	233.3	4,062.8	509.8	504.8	90	2.9	0.3	0.4	1.4	4.3	3
TotalOperatingRevenues_A Operating Rev. Ann.	-23.9%	138.2%	146.7	222.5	4,041.7	509.8	504.8	90	2.9	0.2	0.4	1.3	3.9	2.1
OI_A Other Income Ann.	-	-	14.8	10.8	21.1					0.1	0	0.1	0.3	0.9
OEXPNS_A Operating Exp. Ann.	-23.6%	145.8%	160.5	224.3	4,008.4	502.4	503.1	89.3	2.5	0.2	0.4	1.4	4.2	2.3
OEXPNS_A Operating Exp. Ann.	-23.6%	145.8%	160.5	224.3	4,008.4	502.4	503.1	89.3	2.5	0.2	0.4	1.4	4.2	2.3
OP_A Operating Profit Ann.	-	-	-13.9	-1.8	33.3	7.5	1.7	0.7	0.4	-0.1		-0.1	-0.3	-0.2
OPMPCT_A OPM Ann. %	-	-		-0.78%	0.82%	1.47%	0.34%	0.79%	13.42%	-27.84%	0.23%	-6.88%	-7.00%	-5.51%
TotalExpenses_A Total Exp. Ann. ⌄	-23%	146.9%		229.6	4,012.3	502.4	503.3	89.4	2.5	0.2	0.4	1.4	4.3	2.3
OtherExpenses_A Other Exp. Ann.	21.8%	65.3%	11.5	7.4	6.2	7.5	4.1	1.1	0.6	0.1	0.1	0.1	0.2	0.2
EmployeeBenefitExpenses_A Employee Exp. Ann.	17%	32%	0.7	0.8	0.8	1	0.5	0.2	0.2	0	0.1	0.1	0.1	0.1
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	74.3%	86.4%		9	54.4	7.5	1.7	0.7	0.4	0	0	0	0	0.7
EBIDTPCT_A EBITDA Ann. margin %	124.6%	-22.1%		3.85%	1.34%	1.47%	0.34%	0.79%	13.42%	7.77%	5.01%	0.40%	0.70%	24.48%
INT_A Interest Ann.	275.6%	-	2.3	5.3	3.9	-0.1	0.1						0
DEP_A Depr.	-	-	0	0	0.1	0.2	0.1	0.1	0				0	0
PBT_A PBT Ann.	35.1%	56%	-1.4	3.7	50.5	7.4	1.5	0.7	0.4	0	0		0	0.7
TAX_A Tax Ann.	61.3%	83.8%	0.8	2.1	17.7	2	0.5	0.2	0.1	0				0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	10.9%	38%		1.5	32.7	5.4	1.1	0.5	0.3	0	0		0	0.6
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	10.9%	38%	-2.2	1.5	32.7	5.4	1.1	0.5	0.3	0	0		0	0.6
NETPCT_A NPM Ann. %	47.9%	-41.1%		0.68%	0.80%	1.06%	0.21%	0.53%	9.58%	5.02%	3.91%	0.25%	0.27%	27.67%
EPS_adj_A EPS Adj. latest Ann.	-	-		0	0.4	0.1	0	0						0
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

-94.3%

2Y CAGR

-32.4%

3Y CAGR

-22.7%

5Y CAGR

140.5%

7Y CAGR

148.4%

10Y CAGR

54.6%

Total Revenue Annual is falling faster than historical averages.

Net Profit Ann.

1Y CHG

-95.4%

2Y CAGR

-47.3%

3Y CAGR

10.9%

5Y CAGR

38%

10Y CAGR

9.6%

Net Profit Annual is falling faster than historical averages.

Operating Exp. Ann.

1Y CHG

-94.4%

2Y CAGR

-33.2%

3Y CAGR

-23.6%

5Y CAGR

145.8%

7Y CAGR

147%

10Y CAGR

58.1%

Operating Expenses Annual Cr is falling faster than historical averages.

Supha Pharmachem balance sheet as of Mar 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Supha Pharmachem Mar-2025 Total Shareholders Fund is Rs 43 Cr which is growth of 0.8% YoY.
NEGATIVE
Total Assets Supha Pharmachem Mar-2025 Total Assets is Rs 1,540 Cr which is growth of -21.0% YoY.

Supha Pharmachem Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	106.7%	66.3%	43.3	43	10.4	4.9	3.9	3.4	3.1	3.1	3	3	3
EQCAP_A Equity Share Capital Ann.	123.7%	62.1%	40.3	10.1	3.6	3.6	3.6	3.6	3.6	3.6	3.6	3.6	3.6
TotalShareCapital_A Total Share Capital Ann.	123.7%	62.1%	40.3	10.1	3.6	3.6	3.6	3.6	3.6	3.6	3.6	3.6	3.6
ReservesAndSurplus_A Reserves Plus Surplus Ann.	32.1%	-	3	32.9	6.8	1.3	0.3	-0.3	-0.5	-0.5	-0.6	-0.6	-0.6
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	32.1%	-	3	32.9	6.8	1.3	0.3	-0.3	-0.5	-0.5	-0.6	-0.6	-0.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-	-					10.5	0.4	0.1				0.1
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-
CL_A Total Current Liabilities Ann. ⌄	89.8%	377.9%	1,496.4	1,905	1,143.9	218.8	24.2	0.6	0.4	0.1	0.3	1.5	2.7
TradePayables_A Trade Payables Ann.	37.1%	281%	321	712.3	84.2	124.6	23.8	0.4	0.4			1.4	2.4
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-30.3%	-	31.7	1,135	1,057.1	93.8	0.3			0.1	0.3	0.2	0.2
ShortTermProvisions_A ST Provisions Ann.	66.3%	63%	2.3		2.5	0.5	0.2	0.2	0				0.1
TL_A Total Capital Plus Liabilities Ann.	90.2%	224.2%	1,539.7	1,947.9	1,154.2	223.8	38.5	4.3	3.5	3.1	3.3	4.6	5.8
FixedAssets_A Fixed Assets Ann. ⌄	-	-	0	0.1	0.1	0.2	0.2	0.2		0	0	0	1.4
TangibleAssets_A Tangible Assets Ann.	-	-	0	0.1	0.1	0.1	0.1	0.1		0	0	0	1.4
IntangibleAssets_A Intangible Assets Ann.	-	-				0.1	0.1	0.2
CapitalWorkInProgress_A Capital Work In Progress Ann.	-	-
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	-20.6%	-12.9%	0.1	0.1	0.1	0.2	0.2	0.2		1	1	0.9	2.5
NonCurrentInvestments_A Non Current Investments Ann.	-	-	0.1
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-	0	0	0							0
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-								1	0.9	0.9	1.1
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-	-								0	0
CA_A Total Current Assets Ann. ⌄	90.2%	228.9%	1,539.5	1,947.9	1,154.1	223.6	38.3	4	3.5	2.2	2.3	3.7	3.3
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	109.8%	230.4%	590.9	920.6	172.4	64	23.7	1.5	0.1	2	2.2	2.9	2
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	0%	9.2%	1.4	1.5	21.9	1.4	0.8	0.9	1.1	0	0.2	0	0
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	108.9%	284.9%	675.4	890.4	952	74.1	10.2	0.8	2	0.1		0	0
OtherCurrentAssets_A Other Current Assets Ann.	132.1%	90.4%	2.5	2.1	0.6	0.2	0.6	0.1	0.1	0
TA_A Total Assets Ann.	90.2%	224.2%	1,539.7	1,947.9	1,154.2	223.8	38.5	4.3	3.5	3.1	3.3	4.6	5.8
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-											0
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-	30.2
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	-	-	0.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

-21%

2Y CAGR

15.5%

3Y CAGR

90.2%

5Y CAGR

224.2%

7Y CAGR

142.7%

10Y CAGR

74.7%

Total Assets Annual is falling faster than historical averages.

Total Current Liabilities Ann.

1Y CHG

-21.4%

2Y CAGR

14.4%

3Y CAGR

89.8%

5Y CAGR

377.9%

7Y CAGR

294.9%

10Y CAGR

88.1%

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

0.7%

2Y CAGR

104%

3Y CAGR

106.7%

5Y CAGR

66.3%

7Y CAGR

45.7%

10Y CAGR

30.6%

Total ShareHolders Funds Annual growth is lower than historical averages.

Supha Pharmachem ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Supha Pharmachem Mar-2025 Book Value Per Share is 1 Rs which is growth of -74.8% YoY.
POSITIVE
ROE Supha Pharmachem Mar-2025 ROE is 4% which is growth of 72.7% YoY.

Supha Pharmachem Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15
BVSH_A BVSH Ann.	-56.9%	-34.7%	1.1	4.3	28.8	13.7	10.7	9.3	8.6	8.5	8.4	8.5	8.4
ROA_A RoA Ann. %	-42.8%	-57.5%	0.09%	1.68%	0.47%	0.48%	1.24%	6.48%	0.22%	0.43%	0.10%	0.23%	10.04%
ROE_A ROE Ann. %	-45.5%	-15.6%	3.53%	76.19%	52.35%	21.82%	12.45%	8.25%	0.26%	0.44%	0.11%	0.36%	19.31%
ROCE_A ROCE Ann. %	-14.5%	15.5%	20.67%	126.46%	70.63%	33.04%	4.54%	10.07%	0.60%	0.55%	0.13%	0.66%	23.20%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	130.5%	-21.3%	4.04%	1.34%	1.46%	0.33%	0.79%	13.42%	12.06%	5.25%	0.42%	0.75%	34.96%
PBITMargin_A EBIT Ann. Margin %	132.5%	-20.9%	4.02%	1.34%	1.43%	0.32%	0.72%	12.97%	12.06%	4.85%	0.31%	0.51%	34.40%
PBTMargin_A PBT Ann. Margin %	76.2%	-33.9%	1.64%	1.24%	1.45%	0.30%	0.72%	12.97%	12.06%	4.80%	0.29%	0.27%	34.36%
NETPCT_A NPM Ann. %	47.9%	-41.1%	0.68%	0.80%	1.06%	0.21%	0.53%	9.58%	5.02%	3.91%	0.25%	0.27%	27.67%
ASETTO_A Asset Turnover Ann. %	-70.5%	-32.2%	0.1	2.6	0.7	3.9	4.2	0.7	0.1	0.1	0.3	0.8	0.3
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	0%	-33%	1	1	1	1	1.6	7.4	9.4	31.8	9.1	2.4	1.2
QuickRatio_A Quick Ratio Ann.	14.5%	-31.8%	0.9	1	1	0.6	1.5	6.1	8.9	31.8	9.1	1.9	0.7
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-
EarningRetention_A Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
CashEarningRetention_A Cash Earning Retention Ann. %	-	-
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	192.7%	176.6%	1,213.4	1,149.9	243.7	48.4	25.5	7.5	4.6
EVPerNetSales_A EV Per Net Sales Ann.	280.3%	16.2%	5.5	0.3	0.5	0.1	0.3	2.6	28.7	-	-	-	-
PBV_A Price To Book Value Adjusted	128.9%	51.6%	0.24	0.06	0.01	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03
EVPerEBITDA_A EV Per EBITDA Ann.	68.1%	47.5%	134.9	21.1	32.6	28.4	35.8	19.3	237.5	-	-	-	-
MarketCapPerSales_A Market Cap Per Sales Ann.	44.2%	-36%	0.3	0.3	0.5	0.1	0.2	2.8	35	-	-	-	-
RetentionRatios_A Retention Ratio Ann. %	-	-
EYield_A Earnings Yield Ann.	-	-	0	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.			26.4	1.3			2.7	0.1	0				0

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-95.4%

2Y CAGR

-74%

3Y CAGR

-45.5%

5Y CAGR

-15.6%

7Y CAGR

34.6%

10Y CAGR

-15.6%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-94.6%

2Y CAGR

-56.2%

3Y CAGR

-42.8%

5Y CAGR

-57.5%

7Y CAGR

-20%

10Y CAGR

-37.6%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

5Y CAGR

-33%

7Y CAGR

-39%

10Y CAGR

-1.8%

Current Ratio Annual growth is higher than historical averages.

Supha Pharmachem cash flow: net, operating, investing, and financing flows as of Mar 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEUTRAL
Cash From Operating Activity Supha Pharmachem Mar-2025 Cash From Operating Activity is Rs 0 Cr which is growth of 0% YoY.
POSITIVE
Net Cash Flow Supha Pharmachem Mar-2025 Net Cash Flow is Rs 0 Cr which is growth of 100.0% YoY.

Supha Pharmachem Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16	Mar '15
CFO_A Cash from Operating Act. Ann. ⌄	-	-		-74.2	20.5	11.3	-10.2	-0.2	-0.1	-0.2	0.1	-1.4	0.1
PBT_A PBT Ann.	35.1%	56%	3.7	50.5	7.4	1.5	0.7	0.4	0	0		0	0.7
INT_A Interest Ann.	275.6%	-	5.3	3.9	-0.1	0.1						0
TAX_A Tax Ann.	61.3%	83.8%	2.1	17.7	2	0.5	0.2	0.1	0				0.1
CFI_A Cash from Investing Act. Ann.	-	-			-0	-0.1	-0	-0.2	1.1	0	0.1	1.5	0.1
CFA_A Cash from Financing Act. Ann.	74.6%	251.7%		53.8	-0	-10.6	10.1	0.3	0.1			-0.1	-0.2
NCF_A Net Cash Flow Ann. ⌄	-	-		-20.3	20.4	0.6	-0.1	-0.2	1.1	-0.1	0.2		-0.1
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	189.8%	-		21.9	1.4	0.8	0.9	1.1	0	0.2	0	0	0.2
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	23.3%	6.4%		1.5	21.9	1.4	0.8	0.9	1.1	0	0.2	0	0.1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Financing Act. Ann.

3Y CAGR

74.6%

5Y CAGR

251.7%

Supha Pharmachem investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

New 52W Low today

Supha Pharmachem quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents